This protocol applies to the haemodynamically stable patient presenting with orthodromic atrioventricular re-entrant tachycardia. Haemodynamic stability is the defining feature that determines the initial management pathway.
The recommended pharmacological intervention for this scenario involves intravenous adenosine.
Specific dosing, sequencing, and the complete clinical decision algorithm are contained in the full protocol below.
DOI: 10.1093/eurheartj/ehz467
In orthodromic AVRT, adenosine (6-18 mg i.v. bolus) is recommended if vagal manoeuvres fail and the tachycardia is orthodromic.
View source ↗